Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    cxvascular

    UK MHRA adds capacity for medical device certification

    STS risk calculator uses power of big data to predict cardiac surgery risk

    “Not just inventing the next stent”: The future of medtech relies on patient empowerment

    Onecrea Medical announces successful first-in-human implants of Crea aortic valve

    Latest-generation DCBs “change thinking” on treatment of coronary artery disease

    Ian Meredith joins board of directors at Avertix Medical

    Randomised trial “highly needed” to shed light on effectiveness of TAVI in bicuspid aortic stenosis patients

    Gut bacteria linked to coronary atherosclerotic plaques

    Long-awaited US FDA update finds data do not support excess mortality risk for paclitaxel-coated devices

    Streamlined TAVI pathway paves the way for same-day discharge “record”

    Researchers develop flexible bioresorbable monitor for cardiac patients

    Minimum level of oxygen required during cardiopulmonary bypass “may be lower than previously thought”

    ALL-RISE study of CathWorks FFRangio system enrols first patient

    heart attack

    Depressed ICD patients “more likely to stop medications”

    New arterial hypertension guidelines update recommendations on the use of renal denervation

    AI

    ECG-AI algorithm for early identification of amyloidosis gains US FDA breakthrough designation

    Black patients nearly 50% less likely to receive revascularisation for PAD

    EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis

    FDA

    US FDA seeks to “modernise” clinical trials with new draft guidance

    Research highlights “strikingly low” use of public defibrillators in cardiac arrest

    Early discharge after TAVI: What you need to know

    ADVERTORIAL: Keeping stroke at bay for patients undergoing TAVI

    EuroPCR 2023: Carbon dioxide flushing prior to TAVI may offer protection against brain injury

    EuroPCR 2023: Three-year EBC MAIN results demonstrate need for pragmatism in left main bifurcation stent strategy

    EuroPCR 2023: Imaging technology reduces contrast use during PCI

    ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

    EU ministers approve changes to MDR transition timetable

    Preclinical model could aid future research of NSTEMI therapies

    coronary artery bypass

    “Urgent” action needed to improve outcomes in women undergoing coronary artery bypass surgery

    Renal denervation “can reach new shores”

    SonieVie

    ESC and EAPCI publish renal denervation consensus statement

    TAVI pioneers discuss the past, present and future of transcatheter therapy

    remote monitoring

    Abbott to acquire Cardiovascular Systems

    PCI

    PCI probability seen to increase at low-volume hospitals for all populations, but has not occurred “evenly” across sociodemographic groups

    cardiovascular news top 10

    Cardiovascular News’ top 10 most popular stories of January 2023

    Cardiovascular-aortic community comes together at CX 2023

    Hospitals without high-level designation more likely to miss strokes following TAVI procedures

    NICE lowers threshold for statins to prevent cardiovascular events

    Multidisciplinary teams at the heart of new guidelines on aortic disease management

    Stem cell plasters “could revolutionise treatment of congenital heart disease”

    Corindus rebrands to Siemens Healthineers Endovascular Robotics

    New surgical thresholds and need for multidisciplinary teams reflected in revised aortic guidelines

    EACTS 2022: “Wake up call” for trialists over gender balance

    TCT 2022: UNIVERSAL trial finds ultrasound did not reduce vascular complications during femoral access for cardiac procedures

    TCT 2022 hears “important data” from renal denervation trials

    Precision medicine and upstream interventions in focus at TCT 2022 curtain raiser

    TAVI costs comparable to surgery in low-risk patients, Canadian researchers conclude

    Vascade vascular and venous closure devices gain CE mark

    ESC 2022: Transradial access is “gold standard” approach for percutaneous coronary procedures

    ESC 2022: High-risk aortic stenosis could be picked up using AI

    ESC 2022: SECURE trial finds “polypill” results in lower risk of cardiovascular events compared to usual care

    ESC 2022: Timing of antihypertensive medication “makes no difference” to cardiovascular outcomes

    “Worrisome” rise in cardiovascular disease predicted out to 2060

    Investigational device offers hope of a ‘shortcut’ to prevent coronary obstruction after TAVI

    Stress testing can guide patient selection for coronary revascularisation

    UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year

    Artificial intelligence could make endovascular aortic repair outcomes more predictable

    Women underrepresented in cardiovascular clinical trial leadership positions

    Heart team approach points to mortality benefit in complex cardiac patients

    IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation

    SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation

    Study suggests a more proximal landing zone is preferred for TEVAR of acute type B aortic dissections

    Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection

    Load more

    Most read

    Rafael Sádaba

    Rasha Al-Lamee

    Nicolas Dumonteil

    Cardiovascular News

    Write to us
    Editorial: Will Date [email protected]
    Advertising: Sean Langer [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube